Institution profile

医療法人社団 東京メディカルテラス

Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.

The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →

Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive

MHLW e-Regenerative Medicine public registerPublic document number 02C2601005 +6

Location

Prefecture
Tokyo
Address
港区北青山2-13-4青山MYビル4階

Plan classification

  • Class INot registered
  • Class IINot registered
  • Class IIIThe low-risk category under the law.

Certified committee for regenerative medicine

  • 患者の集いモミの木再生医療等委員会

Public score

37.5/ 100

A · Review level
10.0 / 30
B · Technologies
23.9 / 35
C · Coverage
3.6 / 25
D · Class I / II technologies
0.0 / 10

The public score is calculated from public registration information and does not reflect quality of care. Scoring method →

Overall ranking

No. 1377of 1736

Registered technologies
7
Areas covered
1

Technology areas · Rank

Position in the overall score distribution

0–100 · Public score
000–9.9 · 0 institutions
01010–19.9 · 0 institutions
2172020–29.9 · 217 institutions
3163030–39.9 · 316 institutions
7564040–49.9 · 756 institutions
2465050–59.9 · 246 institutions
1326060–69.9 · 132 institutions
417070–79.9 · 41 institutions
248080–89.9 · 24 institutions
49090–100 · 4 institutions
This institution 37.5
Public score →100

Registered technologies (7)

NK and immune cells 6
Registered technologies · Japanese originalTechnology areasPlan classification
悪性腫瘍に対するαβT細胞療法 (別名:CAT療法[CD3-activated T cell therapy]、活性化自己リンパ球療法[autologous activated lymphocyte therapy])NK and immune cellsClass III
悪性腫瘍に対する活性化自己NK細胞療法NK and immune cellsClass III
癌性胸膜炎による胸水の軽減のための治療(活性化自己リンパ球を中心とした免疫細胞の胸腔内投与)NK and immune cellsClass III
癌性胸膜炎による胸水の軽減のための治療(imDCを中心とした免疫細胞等の胸腔内投与)NK and immune cellsClass III
癌性腹膜炎による腹水の軽減のための治療(活性化自己リンパ球を中心とした免疫細胞の腹腔内投与)NK and immune cellsClass III
癌性腹膜炎による腹水の軽減のための治療(imDCを中心とした免疫細胞等の腹腔内投与)NK and immune cellsClass III
Other 1
Registered technologies · Japanese originalTechnology areasPlan classification
悪性腫瘍に対する細胞性免疫誘導型DCワクチン Cellular immunity inducing DC (CIi-DC)OtherClass III

Certified committee for regenerative medicine

  • 患者の集いモミの木再生医療等委員会

Public document number

  • 02C2601005
  • 02C2601064
  • 02C2601065
  • 02C2601066
  • 02C2601067
  • 02C2601068
  • 02C2601069
Plan classification · Certified committee for regenerative medicine · Public document number
Registered technologiesPlan classificationCertified committee for regenerative medicinePublic document number
悪性腫瘍に対するαβT細胞療法 (別名:CAT療法[CD3-activated T cell therapy]、活性化自己リンパ球療法[autologous activated lymphocyte therapy])Class III患者の集いモミの木再生医療等委員会02C2601005
悪性腫瘍に対する活性化自己NK細胞療法Class III患者の集いモミの木再生医療等委員会02C2601064
悪性腫瘍に対する細胞性免疫誘導型DCワクチン Cellular immunity inducing DC (CIi-DC)Class III患者の集いモミの木再生医療等委員会02C2601065
癌性胸膜炎による胸水の軽減のための治療(活性化自己リンパ球を中心とした免疫細胞の胸腔内投与)Class III患者の集いモミの木再生医療等委員会02C2601066
癌性胸膜炎による胸水の軽減のための治療(imDCを中心とした免疫細胞等の胸腔内投与)Class III患者の集いモミの木再生医療等委員会02C2601067
癌性腹膜炎による腹水の軽減のための治療(活性化自己リンパ球を中心とした免疫細胞の腹腔内投与)Class III患者の集いモミの木再生医療等委員会02C2601068
癌性腹膜炎による腹水の軽減のための治療(imDCを中心とした免疫細胞等の腹腔内投与)Class III患者の集いモミの木再生医療等委員会02C2601069

Other institutions in the same prefecture

← Institution directory
One-to-one advice

Still unsure? Ask an advisor

Use the “Chat with an advisor” button on this page (at the bottom of the screen on mobile, bottom right on desktop) to open a chat with the Stem Cell Japan advice desk. Consultation and coordination are free, and an advisor replies within one working day.

Chat with an advisor